Screener
Corvus Pharmaceuticals CRVS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
FAQ
- What is Corvus Pharmaceuticals's free cash flow?
- Corvus Pharmaceuticals (CRVS) reported free cash flow of -$10.47M in Q1 2026.
- How has Corvus Pharmaceuticals's free cash flow changed year-over-year?
- Corvus Pharmaceuticals's free cash flow decreased by 26.1% year-over-year, from -$8.3M to -$10.47M.
- What is the long-term trend for Corvus Pharmaceuticals's free cash flow?
- Over 2 years (2021 to 2025), Corvus Pharmaceuticals's free cash flow has grown at a -5.2% compound annual growth rate (CAGR), from -$36.72M to -$32.97M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Corvus Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude